FI101701B1 - Menetelmä terapeuttisesti käyttökelpoisten pyridiini-4-karboksyylihappoalkyyliamidi-2-karboksyylihappoamidien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten pyridiini-4-karboksyylihappoalkyyliamidi-2-karboksyylihappoamidien valmistamiseksi

Info

Publication number
FI101701B1
FI101701B1 FI921119A FI921119A FI101701B1 FI 101701 B1 FI101701 B1 FI 101701B1 FI 921119 A FI921119 A FI 921119A FI 921119 A FI921119 A FI 921119A FI 101701 B1 FI101701 B1 FI 101701B1
Authority
FI
Finland
Prior art keywords
carboxylic acid
preparation
therapeutically useful
alkylamide
acid amides
Prior art date
Application number
FI921119A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI101701B (fi
FI921119A (fi
FI921119A0 (fi
Inventor
Ekkehard Baader
Martin Bickel
Volkmar Guenzler-Pukall
Manfred Volz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI921119A0 publication Critical patent/FI921119A0/fi
Publication of FI921119A publication Critical patent/FI921119A/fi
Application granted granted Critical
Publication of FI101701B publication Critical patent/FI101701B/fi
Publication of FI101701B1 publication Critical patent/FI101701B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI921119A 1991-03-18 1992-03-16 Menetelmä terapeuttisesti käyttökelpoisten pyridiini-4-karboksyylihappoalkyyliamidi-2-karboksyylihappoamidien valmistamiseksi FI101701B1 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4108824 1991-03-18

Publications (4)

Publication Number Publication Date
FI921119A0 FI921119A0 (fi) 1992-03-16
FI921119A FI921119A (fi) 1992-09-19
FI101701B FI101701B (fi) 1998-08-14
FI101701B1 true FI101701B1 (fi) 1998-08-14

Family

ID=6427597

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921119A FI101701B1 (fi) 1991-03-18 1992-03-16 Menetelmä terapeuttisesti käyttökelpoisten pyridiini-4-karboksyylihappoalkyyliamidi-2-karboksyylihappoamidien valmistamiseksi

Country Status (22)

Country Link
EP (1) EP0504799B1 (ko)
JP (1) JP3121428B2 (ko)
KR (1) KR100243959B1 (ko)
AT (1) ATE154929T1 (ko)
AU (1) AU645668B2 (ko)
CA (1) CA2063177A1 (ko)
CZ (1) CZ282298B6 (ko)
DE (1) DE59208651D1 (ko)
DK (1) DK0504799T3 (ko)
ES (1) ES2104758T3 (ko)
FI (1) FI101701B1 (ko)
GR (1) GR3024309T3 (ko)
HR (1) HRP940835A2 (ko)
HU (1) HU217809B (ko)
IE (1) IE920843A1 (ko)
IL (1) IL101257A (ko)
MX (1) MX9201156A (ko)
NO (1) NO178859C (ko)
NZ (1) NZ241968A (ko)
TW (1) TW199147B (ko)
YU (1) YU48156B (ko)
ZA (1) ZA921945B (ko)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
ATE113036T1 (de) * 1988-08-04 1994-11-15 Hoechst Ag Verbessertes verfahren zur herstellung von n,n- bis(alkoxyalkyl)-pyridin -2,4- dicarbonsäurediamiden.
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE3928144A1 (de) * 1989-08-25 1991-02-28 Hoechst Ag Zyklische pyridin-2,4- und -2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE3938805A1 (de) * 1989-11-23 1991-05-29 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4030999A1 (de) * 1990-10-01 1992-04-09 Hoechst Ag 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Also Published As

Publication number Publication date
HRP940835A2 (en) 1997-06-30
HUT62565A (en) 1993-05-28
ATE154929T1 (de) 1997-07-15
YU24692A (sh) 1994-06-24
JPH0586032A (ja) 1993-04-06
FI101701B (fi) 1998-08-14
IE920843A1 (en) 1992-09-23
CZ282298B6 (cs) 1997-06-11
NO178859B (no) 1996-03-11
DE59208651D1 (de) 1997-08-07
CS80392A3 (en) 1992-10-14
GR3024309T3 (en) 1997-10-31
AU645668B2 (en) 1994-01-20
KR920018051A (ko) 1992-10-21
NZ241968A (en) 1994-04-27
CA2063177A1 (en) 1992-09-19
AU1296792A (en) 1992-09-24
NO921025L (no) 1992-09-21
EP0504799B1 (de) 1997-07-02
MX9201156A (es) 1992-10-01
IL101257A (en) 1998-03-10
KR100243959B1 (ko) 2000-03-02
HU217809B (hu) 2000-04-28
ES2104758T3 (es) 1997-10-16
HU9200891D0 (en) 1992-05-28
FI921119A (fi) 1992-09-19
FI921119A0 (fi) 1992-03-16
NO921025D0 (no) 1992-03-17
NO178859C (no) 1996-06-19
IL101257A0 (en) 1992-11-15
YU48156B (sh) 1997-05-28
EP0504799A1 (de) 1992-09-23
JP3121428B2 (ja) 2000-12-25
TW199147B (ko) 1993-02-01
ZA921945B (en) 1992-11-25
DK0504799T3 (da) 1998-02-02

Similar Documents

Publication Publication Date Title
HK1006711A1 (en) Substituted heterocyclic carboxylic acid amides their preparation and their use as medicaments
PT81058A (de) Ester der pyridin-2,4- und -2,5-dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
NO174420C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridin-2,4- og 2,5-dikarboksylsyreamider
FI103116B1 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi
DK166619C (da) Fremgangsmaade til fremstilling af n-alkylerede aminosyrer og estere deraf
ZA882449B (en) Dihydropyridinamides,a process for their preparation,and their use in medicaments
FI101701B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridiini-4-karboksyylihappoalkyyliamidi-2-karboksyylihappoamidien valmistamiseksi
NO177187C (no) Analogifremgangsmåte for fremstilling av terapautisk aktive N,N'-bis(alkoksy-alkyl)-pyridin-2,4-dikarboksylsyrediamider
IL106799A (en) Process for the preparation of 2,3-pyridine- dicarboxylic acids from 3-(2-imidazolin-2-yl) picolinic acids
HUT62793A (en) Process for producing locally applicable pharmaceutical compositions comprising lysineclonixinate
DE59307401D1 (de) Alpha-Aryl-alpha-hydroxy-beta-imidazolinylpropionsäureamide